BioTech

GlucoPilot: A real-time, edge-computing AI layer that integrates with existing CGM data to provide sub-second insulin bolus recommendations, reducing manual intervention by 90%.

Type 1 diabetes patients suffer from 'decision fatigue' and hypoglycemic events; current manual dosing takes 15-20 minutes per day, leading to 12-15% HbA1c deviation and $4,500/year in emergency care costs.

View Full Problem Analysis & Blueprint